BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22223210)

  • 1. Inflammation in myocardial diseases.
    Marchant DJ; Boyd JH; Lin DC; Granville DJ; Garmaroudi FS; McManus BM
    Circ Res; 2012 Jan; 110(1):126-44. PubMed ID: 22223210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of myocardial inflammation and dysfunction in burn complicated by sepsis.
    Horton JW
    Shock; 2007 Sep; 28(3):326-33. PubMed ID: 17529909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune receptor activation in viral myocarditis: pathophysiologic implications.
    Tavares PS; Rocon-Albuquerque R; Leite-Moreira AF
    Rev Port Cardiol; 2010 Jan; 29(1):57-78. PubMed ID: 20391900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting the pump: controlling myocardial inflammatory responses.
    Taqueti VR; Mitchell RN; Lichtman AH
    Annu Rev Physiol; 2006; 68():67-95. PubMed ID: 16460267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
    Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
    Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of cardiac inflammation: molecular mechanisms.
    Pankuweit S; Portig I; Maisch B
    Herz; 2002 Nov; 27(7):669-76. PubMed ID: 12439638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial depression in sepsis.
    Fernandes CJ; Akamine N; Knobel E
    Shock; 2008 Oct; 30 Suppl 1():14-7. PubMed ID: 18704015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis, microbes and autoimmunity.
    Whitton JL; Feuer R
    Autoimmunity; 2004 Aug; 37(5):375-86. PubMed ID: 15621561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory alterations in the myocardial microcirculation.
    Hansen PR
    J Mol Cell Cardiol; 1998 Dec; 30(12):2555-9. PubMed ID: 9990527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy in AIDS: a pathophysiological perspective.
    Lewis W
    Prog Cardiovasc Dis; 2000; 43(2):151-70. PubMed ID: 11014331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury.
    Vinten-Johansen J
    Cardiovasc Res; 2004 Feb; 61(3):481-97. PubMed ID: 14962479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the JAK-STAT pathway in myocardial injury.
    Barry SP; Townsend PA; Latchman DS; Stephanou A
    Trends Mol Med; 2007 Feb; 13(2):82-9. PubMed ID: 17194625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, proinflammatory mediators and myocardial ischemia-reperfusion Injury.
    Vinten-Johansen J; Jiang R; Reeves JG; Mykytenko J; Deneve J; Jobe LJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):123-45. PubMed ID: 17258123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms of cardiac disease.
    Lange LG; Schreiner GF
    N Engl J Med; 1994 Apr; 330(16):1129-35. PubMed ID: 8133856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence.
    Vallbracht KB; Schwimmbeck PL; Kühl U; Seeberg B; Schultheiss HP
    Circulation; 2004 Nov; 110(18):2938-45. PubMed ID: 15505098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The innate immune response: an important partner in shaping coxsackievirus-mediated autoimmunity.
    Richer MJ; Horwitz MS
    J Innate Immun; 2009; 1(5):421-34. PubMed ID: 20375600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular involvement in cardiac pathology.
    Gavin JB; Maxwell L; Edgar SG
    J Mol Cell Cardiol; 1998 Dec; 30(12):2531-40. PubMed ID: 9990524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.